Compagnie Lombard Odier SCmA - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 116 filers reported holding INSYS THERAPEUTICS INC NEW in Q3 2017. The put-call ratio across all filers is 1.90 and the average weighting 0.0%.

Quarter-by-quarter ownership
Compagnie Lombard Odier SCmA ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2019$23,000
+35.3%
5,0000.0%0.00%0.0%
Q4 2018$17,000
+70.0%
5,000
+400.0%
0.00%
Q3 2018$10,000
-54.5%
1,000
-66.7%
0.00%
-100.0%
Q2 2018$22,000
+22.2%
3,0000.0%0.00%0.0%
Q1 2018$18,000
-69.0%
3,000
-50.0%
0.00%0.0%
Q4 2017$58,000
+114.8%
6,000
+100.0%
0.00%0.0%
Q3 2017$27,000
-53.4%
3,000
+200.0%
0.00%
-50.0%
Q1 2015$58,0001,0000.00%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q3 2017
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 1$00.00%
View complete list of INSYS THERAPEUTICS INC NEW shareholders